USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ypsomed Ag

USPTO PatentsView assignee record — 71 granted patents across 18 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

71
Total patents granted
18
CPC technology areas
16.5
Avg claims per patent
5-year filing velocity

The verdict

Ypsomed holds 71 US patents across 18 technology areas — rank #4,930 of 50,000 tracked assignees.

#4,930
of 50,000 US assignees by volume
Top 5%
by Innovation Score (57.2/100)
16.5
avg claims per patent

Portfolio overview

Ypsomed AG has been granted 71 US utility patents between 2020 and 2025, placing Ypsomed AG at rank #4,930 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.5 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Ypsomed AG is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 57.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 71 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Ypsomed AG's 16.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ypsomed AG against peers pursuing similar technology classes.

How does Ypsomed compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Ypsomed holds 71 patents — placing it at rank #4,930 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

Ypsomed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

57 Top 5% higher than 95% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

05101520 202020212022202320242025 13
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Ypsomed AG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 3 4.2%
2021 13 18.3%
2022 16 22.5%
2023 7 9.9%
2024 19 26.8%
2025 13 18.3%

Which technologies does Ypsomed AG patent most?

Top 15 of 18 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard

Where it ranks

Overall rank by patents

#4,930

Across all tracked assignees

Innovation Score

57.2 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Ypsomed AG hold?
Ypsomed AG holds 71 US granted patents filed between 2020 and 2025, spanning 18 technology areas.
What is Ypsomed AG's Innovation Score?
Ypsomed AG has an Innovation Score of 57.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Ypsomed AG focus on?
Ypsomed AG's top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 66 patents. The company has filed patents in 18 CPC subclasses total.
Is Ypsomed AG's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Ypsomed AG.
What does claim depth mean for Ypsomed AG's patents?
Ypsomed AG's patents average 16.5 claims each. This falls within the standard range, providing solid legal coverage.
How is the Ypsomed AG patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

Ypsomed's 71 grants land it in the top 5% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Ypsomed ranks #4,930 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61M — see who else leads that technology area. A61M leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov